Summary:
A randomized, double-blind placebo, and active controlled parallel group multicenter study to evaluate the efficacy and safety of induction and maintenance therapy in patients with moderate to severe UC.
Criteria:Be between the ages of 18 and 65.
A documented diagnosis of UC more than 12 weeks prior to the screening.
Moderate to Severe UC.
Qualified Participants May Receive:
Up to $1300 for time and travel.